In addition to the anti-tumor activities described for various phytochemicals and herbal extracts, their ability to inhibit ABC transporters and modulate MDR highlights these products as potential co-adjuvants for conventional cancer treatment [85,86]. This evidence concerns the gene ABCG2 and neoplasm.